Physician profile
Jeffrey S Peller
NPI 1497810808
$3,046.92
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $849 · 2020: $448 · 2021: $358 · 2022: $448 · 2023: $622 · 2024: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763 · Education: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $762.50 |
| Education | $181.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $748.42 | 2019-2024 | |
| Amgen INC. | $720.27 | 2019-2024 | Enbrel, Tavneos, Otezla |
| Pfizer INC. | $326.26 | 2019-2023 | |
| Janssen Biotech, INC. | $265.09 | 2019-2024 | Tremfya |
| Novartis Pharmaceuticals Corporation | $206.37 | 2019-2024 | |
| Aurinia Pharma U.S., INC. | $138.70 | 2021-2023 | Lupkynis |
| Glaxosmithkline, LLC. | $107.48 | 2019-2024 | Benlysta, Nucala |
| Horizon Therapeutics Plc | $102.04 | 2019-2023 | Krystexxa |
| Astrazeneca Pharmaceuticals LP | $70.09 | 2022-2023 | Saphnelo |
| Ucb, INC. | $67.59 | 2022-2023 | Cimzia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.30 | 2020-2024 | |
| Genentech USA, INC. | $59.02 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $57.61 | 2019-2020 | |
| Lilly USA, LLC | $28.86 | 2019 | |
| Janssen Scientific Affairs, LLC | $27.36 | 2019-2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $19.25 | 2024 | |
| Radius Health, INC. | $17.82 | 2024 | Tymlos |
| Sandoz INC. | $17.39 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Peller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.